Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.06 USD | -0.94% | -7.88% | -21.89% |
Apr. 24 | Arvinas, Inc. Appoints Randy Teel as Chief Business Officer | CI |
Apr. 15 | H.C. Wainwright Cuts Price Target on Arvinas to $87 From $90, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.89% | 2.21B | |
-2.41% | 103B | |
+1.74% | 95.28B | |
+1.46% | 22.15B | |
-15.68% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.01% | 16.05B | |
+5.28% | 13.68B | |
+35.00% | 12.17B |
- Stock Market
- Equities
- ARVN Stock
- News Arvinas, Inc.
- Novartis Secures Exclusive Licensing Deal with Arvinas for Prostate Cancer Drug